Documentation
Description:
RATHL is a multicentre, randomised, phase III trial comparing treatment outcome for patients with advanced Hodgkin lymphoma, using FDG-PET imaging after 2 cycles of ABVD to determine response and subsequent management.
Recruitment target: 1200 patients
Patients received 2 cycles of ABVD and then had a PET-CT scan. PET negative patients were randomised to either ABVD or AVD for a further 4 cycles. PET positive patients received either BEACOPP-14, for 4-6 cycles or BEACOPP escalated, for 3-4 cycles.
Samples collected for trial: Formalin fixed paraffin embedded tumour block - sent to HMDS, Leeds. Blood sample to be analysed at site. Blood sample - sent to Simpson Centre for Reproductive Health, Edinburgh.
Coverage
Spatial:
United Kingdom,England
Typical Age Range:
15-150
Provenance
Temporal
Start Date:
01 January 2008
Time Lag:
Variable
Accessibility
Access
Access Rights:
Please contact the publisher using Contact Point details provided
Access Request Cost:
Not specified
Delivery Lead Time:
Not applicable
Data Controller:
University College London
Usage
Resource Creators:
In Progress
Format and Standards
Vocabulary Encoding Schemes:
LOCAL
Languages:
en
Formats:
In Progress